Latest Articles

Publication Date
Expanded Same Day Surgeries For Additional Procedures - Mirage News

Expanded Same Day Surgeries For Additional Procedures Mirage News

Published: May 31, 2026, 11:22 p.m.
Challenges in treating advanced endometriosis highlighted - newsdrum.in

Challenges in treating advanced endometriosis highlighted newsdrum.in

Published: May 31, 2026, 3:05 p.m.
Challenges in treating advanced endometriosis highlighted - ThePrint

Challenges in treating advanced endometriosis highlighted ThePrint

Published: May 31, 2026, 2:49 p.m.
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients - Cancer Therapy Advisor

Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients Cancer Therapy Advisor

Published: May 30, 2026, 4 a.m.
Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC - CancerNetwork

Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC CancerNetwork

Published: May 30, 2026, 12:40 a.m.
Contributions of T-helper 9 cells in endometriosis-associated inflammation and lesion growth.

Endometriosis is an inflammatory gynecologic disease characterized by ectopic growth of endometrial-like tissue, resulting in pelvic pain and infertility. T-helper 9 (Th9) cells play a known role in various chronic …

Published: May 30, 2026, midnight
Dental pulp-derived mesenchymal stem cells reduce lesion progression in a rat model of endometriosis.

Endometriosis is a chronic, estrogen-dependent inflammatory disease sustained by aberrant angiogenesis and progressive fibrosis. We evaluated the therapeutic efficacy of human dental pulp-derived mesenchymal stem cells (DP-MSCs) in a surgically …

Published: May 30, 2026, midnight
Quality of AI-generated post-operative patient education after minimally invasive gynecologic surgery: A comparative analysis.

To compare the quality of AI-generated responses to gynecologic post-operative questions with educational materials published by professional societies.

Published: May 30, 2026, midnight
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer - OncLive

Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer OncLive

Published: May 29, 2026, 11:57 p.m.
Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer - Targeted Oncology

Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer Targeted Oncology

Published: May 29, 2026, 10:11 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!